Looking to unlock deeper data-driven insights or to build more intelligent business process automations? These popular tools ...
The Trump administration’s consolidation of identity systems signals a push toward centralized data control under the banner ...
ThePrint on MSN
When a garbage pile sparked innovation—the story of Civinc, civic data app making governance ‘visible’
Student-built app, conceived by Aishwarya Sunaad during her time at Ashoka University, was launched this month in Nanjangud, ...
Knowledge management can help institutional teams become more familiar with their enterprise artificial intelligence tools ...
AI challenges traditional literacy and scholarly roles but cannot replicate human creativity in asking novel questions, which ...
Agentic AI marketplace brings plug-and-play tools and onchain payments to small businesses around the world, pairing audited ...
WhatsApp's misjudged joke has left some users questioning the validity of the company's end-to-end encryption system.
New innovations make it easier for enterprises to unite defenses across identity, data, applications, and operations by applying AI. WATERLOO, ON, Oct. /CNW/ — OpenText™ (NASDAQ: OTEX) ...
TORONTO, ON / ACCESS Newswire / October 29, 2025 / Route1 Inc. (TSXV:ROI) ("Route1" or the "Company"), a leading engineering and professional services firm specializing in the deployment and integrati ...
Modern Engineering Marvels on MSN
Grammarly’s Surprising Rebrand to Superhuman and Launch of AI Assistant
Might a name change presage the future of workplace AI? When you think about it, Grammarly’s move to rebrand its corporate identity as “Superhuman” after acquiring the high-speed email client of the ...
New corporate brand reflects strategic transformation to a global biotech platform accelerating access to innovative medicines for patients worldwide Strategy centers on broadening access to global ...
Compelling results set new clinical standard in generalized myasthenia gravis (gMG), increasing confidence in the Company's registrational KYSA-6 Phase 3 MG trial 100% of patients achieved clinically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results